Regulatory effects of IFN-β on the development of experimental Autoimmune Uveoretinitis in B10RIII mice

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Sun, Min ^a   Yang, Yan ^a,b   Yang, Peizeng ^a   Lei, Bo ^a   Du, Liping ^a   Kijlstra, Aize ^c  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA INTERFERON; CD28 ANTIBODY; CD3 ANTIBODY; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN[161-180]; L SELECTIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD62L+ T CELL; CD4+ CD62L- T CELL; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; EFFECTOR CELL; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; IMMUNIZATION; INTERFERON PRODUCTION; LYMPH NODE CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; UVEORETINITIS; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PATHOLOGY; RETINITIS; UVEITIS;

MUS;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-BETA; INTERFERON-GAMMA; INTERLEUKINS; MICE; MONOCYTES; RETINITIS; TH1 CELLS; TH17 CELLS; UVEITIS;

EID: 79955790086     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019870     Document Type: Article

References (45)

1. Liu YJ, (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
2. Durelli L, Conti L, Clerico M, Boselli D, Contessa G, et al. (2009) T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol 65: 499-509.
3. Zhang X, Markovic-Plese S, (2010) Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis. Clinical Neurology and Neurosurgery 112: 641-645.
4. Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, et al. (1999) Interferon beta induces T-helper 2 immune deviation in MS. Neurology 53: 1692-1697.
5. Zang Y, Hong J, Robinson R, Li S, Rivera VM, et al. (2003) Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. J Neuroimmunol 137: 144-153.
6. Martin-Saavedra FM, Gonzalez-Garcia C, Bravo B, Ballester S, (2008) Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells. Mol Immunol 45: 4008-4019.
7. Ersoy E, Kus CN, Sener U, Coker I, Zorlu Y, (2005) The effects of interferon-beta on interleukin-10 in multiple sclerosis patients. Eur J Neurol 12: 208-211.
8. Yong VW, Chabot S, Stuve O, Williams G, (1998) Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 51: 682-689.
9. Chen M, Chen G, Nie H, Zhang X, Niu X, et al. (2009) Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. European Journal of Immunology 39: 2525-2536.
10. Mosmann TR, Coffman RL, (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
11. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR, (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6: 169-175.
12. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
14. Dardalhon V, Korn T, Kuchroo VK, Anderson AC, (2008) Role of Th1 and Th17 cells in organ-specific autoimmunity. Journal of Autoimmunity 31: 252-256.
15. Hegelich BM, Albright BJ, Cobble J, Flippo K, Letzring S, et al. (2006) Laser acceleration of quasi-monoenergetic MeV ion beams. Nature 439: 441-444.
16. Steinman L, (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13: 139-145.
17. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
18. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, et al. (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140: 1490-1495.
19. Nussenblatt RB, (1991) Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Vis Sci 32: 3131-3141.
20. Luger D, Silver PB, Tang J, Cua D, Chen Z, et al. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205: 799-810.
21. Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, et al. (2008) Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 20: 209-214.
22. Teige I, Treschow A, Teige A, Mattsson R, Navikas V, et al. (2003) IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 170: 4776-4784.
23. Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S, (2009) IFN-beta inhibits human Th17 cell differentiation. J Immunol 183: 5418-5427.
24. Steinman L, (2009) Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN. Eur J Immunol 39: 2358-2360.
25. Plskova J, Greiner K, Forrester JV, (2007) Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis. American Journal of Ophthalmology 144: 55-61.
26. Deuter CM, Kotter I, Gunaydin I, Stubiger N, Doycheva DG, et al. (2009) Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. British Journal of Ophthalmology 93: 906-913.
27. Warde N, (2010) Therapy: Behcet uveitis: good results for IFN-alpha-2a. Nat Rev Rheumatol 6: 437.
28. Okada AA, Keino H, Fukai T, Sakai J, Usui M, et al. (1998) Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocular Immunology and Inflammation 6: 215-226.
29. Stubiger N, Crane IJ, Kotter I, Lamont GR, Zoeller M, et al. (2003) Interferon alpha 2a in IRPB-derived peptide-induced EAU-part I. Advances in Experimental Medicine and Biology 528: 537-540.
30. Suzuki J, Sakai J, Okada AA, Takada E, Usui M, et al. (2002) Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis. Graefes Arch Clin Exp Ophthalmol 240: 314-321.
31. Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM, (2004) The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J Interferon Cytokine Res 24: 131-139.
32. Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR, (1998) IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 10: 807-814.
33. Somani AK, Swick AR, Cooper KD, McCormick TS, (2008) Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling. Archives of Dermatology 144: 1341-1349.
34. Crow MK, (2010) Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheumatic Diseases Clinics of North America 36: 173-186, x.
35. Scheu S, Dresing P, Locksley RM, (2008) Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proceedings of the National Academy of Sciences of the United States of America 105: 20416-20421.
36. Hedegaard CJ, Krakauer M, Bendtzen K, Sorensen PS, Sellebjerg F, et al. (2008) The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis. Clin Immunol 129: 80-89.
37. Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, et al. (2010) T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 16: 406-412.
38. McRae BL, Semnani RT, Hayes MP, van Seventer GA, (1998) Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160: 4298-4304.
39. Caspi RR, (2002) Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. International Reviews of Immunology 21: 197-208.
40. Berenson LS, Ota N, Murphy KM, (2004) Issues in T-helper 1 development-resolved and unresolved. Immunological Reviews 202: 157-174.
41. Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, et al. (2009) IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 182: 3928-3936.
42. Guo B, Chang EY, Cheng G, (2008) The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. Journal of Clinical Investigation 118: 1680-1690.
43. Chang EY, Guo B, Doyle SE, Cheng G, (2007) Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 178: 6705-6709.
44. Sun M, Yang P, Du L, Zhou H, Ren X, et al. (2010) Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 51: 383-389.
45. Caspi RR, (2003) Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol Chapter 15: Unit 15 16.